Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study

Table 1 Clinical and pathological characteristics in control and adjuvant TACE groups patients without risk factors for residual tumor

Characteristics	Control	Adjuvant TACE	P value
	(n = 174)	group (n = 77)
Gender
Female	34	5	0.009
Male	140	72
Age (mean ± SD)	50.86 ± 11.61	49.35 ± 10.04	0.323
HBsAg
Positive	43	11	0.135
Negative	131	66
Cirrhosis
Absent	22	6	0.130
Mild	53	33
Severe	99	38
Child-pugh Class
A	165	77	0.134
B	5	0
AFP (mean ± SD, ug/L)	333.91 ± 529.92	406.04 ± 735.16	0.381
TNM classification
I	28	19	0.108
II	146	58